Back to top
more

MOONLAKE IMMUNO (MLTX)

(Real Time Quote from BATS)

$44.50 USD

44.50
168,436

+1.44 (3.34%)

Updated Aug 8, 2024 11:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Wall Street Analysts Believe MoonLake Immunotherapeutics (MLTX) Could Rally 26.97%: Here's is How to Trade

The consensus price target hints at a 27% upside potential for MoonLake Immunotherapeutics (MLTX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Is MoonLake Immunotherapeutics (MLTX) Stock a Solid Choice Right Now?

MoonLake Immunotherapeutics (MLTX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

ACELYRIN (SLRN) Fails to Meet Goal in HS Study, Stock Down 54%

ACELYRIN (SLRN) fails to achieve statistically significant primary endpoint result in the hidradenitis suppurativa study of its lead candidate, izokibep. The stock of the company falls 54%.

Biotech Stock Roundup: SRPT's DMD Therapy Approval, ICPT's Setback & More Updates

Regulatory updates from Sarepta (SRPT) and Intercept (ICPT) are in focus in the biotech sector.

MoonLake Immunotherapeutics (MLTX) Is a Great Choice for 'Trend' Investors, Here's Why

MoonLake Immunotherapeutics (MLTX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Why MoonLake (MLTX) Might Surprise This Earnings Season

MoonLake (MLTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Here's Why Momentum in MoonLake Immunotherapeutics (MLTX) Should Keep going

If you are looking for stocks that are well positioned to maintain their recent uptrend, MoonLake Immunotherapeutics (MLTX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

MoonLake Immunotherapeutics (MLTX) is on the Move, Here's Why the Trend Could be Sustainable

If you are looking for stocks that are well positioned to maintain their recent uptrend, MoonLake Immunotherapeutics (MLTX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

What Makes MoonLake Immunotherapeutics (MLTX) a New Buy Stock

MoonLake Immunotherapeutics (MLTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.